Login to Your Account

Other News To Note

Wednesday, February 13, 2013
• ImmunoGenes AG, of Zug, Switzerland, reported the incorporation of ImmunoGenes-ABS Zrt in Gödöllő, Hungary, as a fully owned subsidiary that will formalize the development and production of monoclonal and polyclonal antibodies for a commercial program called Customized Antibody Solutions.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription